Weigao Co., Ltd. (01066) and PT Oneject Indonesia formed a joint venture in Indonesia to enter emerging overseas markets

Zhitongcaijing · 11/10/2025 09:41

Zhitong Financial App News, Weigao Co., Ltd. (01066) announced that on November 6, 2025, Weigao International Holding Corporation Pte. Ltd. (Weigao International Holdings) and PT Oneject Indonesia (joint venture partner) entered into a joint venture agreement to establish a joint venture Oneject Wego Medical (joint venture) in Indonesia. The joint venture will have 45% of the shares held by Weigao International Holdings and 55% of the joint venture partners. Joint ventures are recorded as corporate joint ventures and their financial results will not be comprehensively included in the company's accounts.

The joint venture's business activities include manufacturing and selling intravenous indentation needles, infusion sets and other medical consumables in Indonesia. It will continue to focus on localized production. The target products are products that Indonesia currently relies heavily on imports.

The joint venture partner is a company incorporated in Indonesia and a subsidiary of GDK Company (a leading Indonesian enterprise group integrating manufacturing and sales operations). The joint venture partners mainly produce standard syringes, safe and intelligent automatically disabled syringes, blood bags, hemodialysis and blood collection tubes. As one of Indonesia's leading manufacturers, joint venture partners enable joint ventures to use their extensive resources, mature networks and deep market knowledge to find suitable business opportunities in the Indonesian market. As far as the company knows, the ultimate beneficial owner of a joint venture partner is independent of the company and its related persons.

The board of directors believes that the establishment of a joint venture will enable the Group to enter emerging overseas markets, expand its customer base, and generate synergy benefits with the Group's existing business. In view of the above, the Board of Directors believes that the establishment of a joint venture is in the overall interests of the company and shareholders.